+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

From
From
Topiramate (CAS 97240-79-4) Global Market Research Report 2024 - Product Thumbnail Image

Topiramate (CAS 97240-79-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Sibutramine (CAS 106650-56-0) Global Market Research Report 2024 - Product Thumbnail Image

Sibutramine (CAS 106650-56-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Rimonabant (CAS 168273-06-1) Global Market Research Report 2024 - Product Thumbnail Image

Rimonabant (CAS 168273-06-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Phentermine (CAS 122-09-8) Global Market Research Report 2024 - Product Thumbnail Image

Phentermine (CAS 122-09-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Orlistat (CAS 96829-58-2) Global Market Research Report 2024 - Product Thumbnail Image

Orlistat (CAS 96829-58-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
Lorcaserin (CAS 616202-92-7) Global Market Research Report 2024 - Product Thumbnail Image

Lorcaserin (CAS 616202-92-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Benzphetamine (CAS 101-47-3) Global Market Research Report 2024 - Product Thumbnail Image

Benzphetamine (CAS 101-47-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Bupropion (CAS 34911-55-2) Global Market Research Report 2024 - Product Thumbnail Image

Bupropion (CAS 34911-55-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more